Gut microbiota and pathobiont exposure influences disease incidence in non-obese diabetic mice
Frontiers in Microbiology · 23.07.2026 · 17
DOI: 10.3389/fmicb.2026.1844128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 23.07.2026. Verfasst von Amber L Russell und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathobiology and Integrative Biomedical Sciences, College of Veterinary Medicine, University of Missouri, Columbia, MO, United States. Die Arbeit nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Office of Research Infrastructure Programs.
Abstract (Originalsprache)
While the non-obese diabetic (NOD) mouse is the most widely used animal model of type 1 diabetes (T1D), it suffers from poor reproducibility in disease incidence often attributed to variables in the environment, including the gut microbiota (GM). Prior research suggests a protective effect of segmented filamentous bacteria (SFB) on disease incidence, but it is unclear whether other pathobiont organisms or resident GM affect disease incidence. The objectives of the current study were to determine the effect of supplier-origin GMs and three different microbial challenges (SFB, Helicobacter hepaticus , and Mouse Hepatitis Virus [MHV]) on early-stage insulitis and lifelong disease incidence in NOD mice. The fecal microbiome was assessed pre- and post-disease onset to identify shifts in composition and predicted function of the GM. Results show that all three microbes influence T1D incidence and insulitis severity. Overall, SFB, MHV, and a high-richness microbiome were associated with lower disease incidence, while H. hepaticus and a low-richness microbiome were associated with higher disease incidence. H. hepaticus , but not SFB or MHV, was associated with significant changes in beta-diversity of the GM. While immune outcomes were not included, these findings provide guidance on microbes affecting disease incidence in NOD mice and evidence that such microbes may contribute to poor reproducibility in NOD mice or other mouse models.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathobiology and Integrative Biomedical Sciences, College of Veterinary Medicine, University of Missouri, Columbia, MO, United States.
- Comparative Medicine Program, University of Missouri, Columbia, MO, United States.
- The Jackson Laboratory, Bar Harbor, ME, United States.
- University of Missouri Mutant Mouse Resource and Research Center (MU MMRRC), University of Missouri, Columbia, MO, United States.
- University of Missouri Metagenomics Center (MUMC), University of Missouri, Columbia, MO, United States.
Förderung
- NIH HHS
- Office of Research Infrastructure Programs
Zitieren
APA
Russell, A. L., Olthoff, B., Zhang, C., Lutz, C., Franklin, C. L., & Ericsson, A. C. (2026). Gut microbiota and pathobiont exposure influences disease incidence in non-obese diabetic mice. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1844128
Vancouver
Russell AL, Olthoff B, Zhang C, Lutz C, Franklin CL, Ericsson AC. Gut microbiota and pathobiont exposure influences disease incidence in non-obese diabetic mice. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1844128
BibTeX
@article{Russell2026,
author = {Russell, Amber L and Olthoff, Benjamin and Zhang, Chunye and Lutz, Cat and Franklin, Craig L and Ericsson, Aaron C},
title = {Gut microbiota and pathobiont exposure influences disease incidence in non-obese diabetic mice},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1844128}
}
EUVIMED